Domzalski David 4
4 · VYNE Therapeutics Inc. · Filed Jul 5, 2023
Insider Transaction Report
Form 4
Domzalski David
DirectorPRESIDENT AND CEO
Transactions
- Tax Payment
Common Stock
2023-06-30$4.10/sh−981$4,022→ 52,433 total
Footnotes (1)
- [F1]Represents shares that have been withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units.